Stanford Medicine's comprehensive investigations extend from the earliest phase of basic discovery to the development of new diagnostics, treatment protocols and approaches to health-care delivery and preventive medicine.
Translational Research Centers
Close integration across Stanford Medicine's research and health-care missions enables researchers and clinician-scientists to identify how emerging scientific insights can be applied to patient care while safely evaluating new approaches to preventing, diagnosing and treating disease through clinical trials.
Stanford Center for Clinical and Translational Research and Education
The Stanford Center for Clinical and Translational Research and Education, called Spectrum, is a Stanford independent research center partially funded by a Clinical and Translational Science Award from the National Institutes of Health. Its goal is to accelerate and enhance medical research, from basic discovery to improved patient care.
Freidenrich Center for Translational Research
The Freidenrich Center is a state-of-the-art facility for conducting human-subject clinical trials. Available for use by all Stanford researchers, the center features 27 patient stations, an infusion center, a sample-collection lab and a pediatric area. It is also home to staff members of Spectrum and the Stanford Cancer Institute.
This biomedical technology innovation program assembles teams of medical, engineering and business students to develop solutions to address unmet medical needs. It includes fellowships, innovation grants, med-tech innovation classes, mentoring in the technology transfer process, career services and community educational events.
This drug-discovery program teaches an innovative way to overcome the hurdles associated with translating discoveries into therapeutics that address real clinical needs. It offers innovation grants, lab access, and mentors in drug discovery, product development, trial design, regulatory science and intellectual property law.
The Stanford Predictives and Diagnostics Accelerator program supports projects that predict the onset or course of disease and improve health. It offers innovation grants, events and mentors in the areas of discovery, development, trial design, regulations and intellectual property law.
Population Health Sciences
The Population health sciences initiative facilitates information exchange, collaboration and resource sharing among faculty, staff, students and community partners interested in population health. It also offers innovation grants for population health and community engagement projects. Organizers are also working to build interdisciplinary teams to design and implement the learning health-care systems of the future.
Clinical Excellence Research Center
CERC organizes research teams from across the university to design and test new health care delivery methods that reduce disability and annual per-capita health spending. Research is led by teams of post-doctoral scholars and mentored by faculty from business, engineering and medicine.
Advancing Cancer Care
The clinician-scientists of the Stanford Cancer Institute are engaged in more than 250 clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.
Stanford Cancer Institute Clinical Trials
Stanford Medicine offers patients direct access to clinical trials that safely evaluate new ways to prevent, diagnose and treat disease. Currently more than 500 trials are underway.